G-CSF upregulates Bv8 expression in neutrophils, facilitating neutrophil recruitment to tumors and promoting angiogenesis, which ultimately result in resistance to anti-VEGF therapy in tumor xenografts [119] and spontaneous CRC mouse models [120]. This evidence concerns the gene PROK2 and neoplasm.